A high-throughput customized cytokinome screen of colon cancer cell responses to small-molecule oncology drugs
Open Access
- 28 September 2021
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 12 (20) , 1980-1991
Abstract
Https://doi.org/10.18632/oncotarget.28079 Kelsey E. Huntington, Anna Louie, Lanlan Zhou, Wafik S. El-DeiryKeywords
This publication has 47 references indexed in Scilit:
- Chemokine CXCL14 is associated with prognosis in patients with colorectal carcinoma after curative resectionJournal of Translational Medicine, 2013
- Tumor-Derived Chemokine CCL5 Enhances TGF-β–Mediated Killing of CD8+ T Cells in Colon Cancer by T-Regulatory CellsCancer Research, 2012
- Interleukin-6 - A Key Regulator of Colorectal Cancer DevelopmentInternational Journal of Biological Sciences, 2012
- Expression of HIF-1alpha and VEGF in colorectal cancer: association with clinical outcomes and prognostic implicationsBMC Cancer, 2009
- Eotaxin-2 and Colorectal Cancer: A Potential Target for Immune TherapyClinical Cancer Research, 2007
- Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosisClinica Chimica Acta, 2007
- Combination of MIG (CXCL9) chemokine gene therapy with low-dose cisplatin improves therapeutic efficacy against murine carcinomaGene Therapy, 2006
- Expression and function of vascular endothelial growth factor receptor-1 on human colorectal cancer cellsOncogene, 2005
- Cytokine and Cytokine Receptor Pleiotropy and RedundancyJournal of Biological Chemistry, 2002
- Interleukin‐7 (IL‐7) in Colorectal Cancer: IL‐7 is Produced by Tissues from Colorectal Cancer and Promotes Preferential Expansion of Tumour Infiltrating LymphocytesScandinavian Journal of Immunology, 1997